Profile data is unavailable for this security.
About the company
Modivcare Inc. is a technology-enabled healthcare services company that provides a suite of integrated supportive care solutions for public and private payors and their members. It provides non-emergency medical transportation (NEMT), personal care services (PCS), and in-home monitoring solutions (Monitoring). Its segments include NEMT, PCS, Monitoring, and Corporate and Other. The NEMT segment provides non-emergency medical transportation services throughout the country. The PCS segment provides nonmedical personal care and home health services. Additionally, services provided in its PCS segment include placements of non-medical personal care assistants, home health aides and nurses primarily to Medicaid patient populations in need of care monitoring and assistance performing daily living activities in the home setting. The Monitoring segment provides monitoring solutions. It provides in-home monitoring services to support patient self-management and care management operations.
- Revenue in USD (TTM)2.75bn
- Net income in USD-229.36m
- Incorporated1996
- Employees23.68k
- LocationModivCare Inc6900 LAYTON AVENUE, 12TH FLOORDENVER 80237United StatesUSA
- Phone+1 (720) 258-2130
- Fax+1 (520) 747-6605
- Websitehttps://modivcare.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Elite Health Systems Inc | 0.00 | -2.17m | 24.62m | 3.00 | -- | 5.82 | -- | -- | -0.113 | -0.113 | 0.00 | 0.1975 | 0.00 | -- | -- | 0.00 | -62.73 | -31.33 | -93.01 | -40.26 | -- | -- | -- | -115.33 | -- | -4.11 | 0.00 | -- | -- | -- | -151.84 | -- | -- | -- |
| Jun An Kang Group Inc | 4.47m | -3.25m | 30.91m | 0.00 | -- | -- | -- | 6.91 | -1,128.15 | -1,128.15 | 24.83 | -3.45 | 1.25 | -- | 8.10 | -- | -91.08 | -- | -654.07 | -- | 49.14 | -- | -72.75 | -- | -- | -1.82 | 2.94 | -- | 39.82 | -- | -15.35 | -- | -- | -- |
| Cryo-Cell International Inc | 32.10m | 128.71k | 38.79m | 82.00 | 398.34 | -- | 39.40 | 1.21 | 0.012 | 0.012 | 3.93 | -1.81 | 0.5092 | 10.46 | 4.61 | 391,497.10 | 0.2042 | -0.2232 | 0.3029 | -0.3362 | 75.79 | 71.48 | 0.4009 | -0.4164 | 0.5423 | 3.40 | -- | -- | 2.05 | 0.1064 | 104.22 | -29.39 | 29.41 | -- |
| Zomedica Corp | 27.52m | -101.63m | 39.30m | 152.00 | -- | 0.2967 | -- | 1.43 | -0.1037 | -0.1037 | 0.0281 | 0.1352 | 0.1424 | 1.56 | 12.09 | 181,072.40 | -52.56 | -13.58 | -54.75 | -14.00 | 70.40 | -- | -369.26 | -177.17 | 9.16 | -- | 0.00 | -- | 8.33 | -- | -36.07 | -- | 58.14 | -- |
| Basel Medical Group Ltd | 7.81m | 335.33k | 42.27m | 36.00 | 123.81 | 7.32 | 116.60 | 5.41 | 0.0182 | 0.0182 | 0.4232 | 0.3074 | 0.6325 | -- | 6.39 | 216,958.60 | 2.72 | -- | 5.18 | -- | -- | -- | 4.29 | -- | 1.87 | 6.20 | 0.3758 | -- | 3.60 | -- | 16.23 | -- | -- | -- |
| Biodesix Inc | 74.46m | -40.42m | 45.23m | 273.00 | -- | 4.09 | -- | 0.6074 | -0.2867 | -0.2867 | 0.5246 | 0.0755 | 0.8587 | -- | 8.49 | 272,758.30 | -46.61 | -51.25 | -62.71 | -72.81 | 78.38 | 63.18 | -54.28 | -90.86 | -- | -4.37 | 0.7685 | -- | 45.30 | 23.77 | 17.67 | -- | 19.43 | -- |
| Burning Rock Biotech Ltd (ADR) | 73.00m | -33.28m | 45.40m | 674.00 | -- | 0.5689 | -- | 0.6219 | -3.22 | -3.22 | 7.01 | 7.41 | 0.5689 | 2.32 | 3.12 | 108,310.60 | -25.94 | -37.64 | -35.83 | -45.81 | 71.49 | 69.83 | -45.59 | -124.32 | 2.76 | -- | 0.00 | -- | -4.02 | 6.21 | 46.97 | -- | -33.43 | -- |
| ModivCare Inc | 2.75bn | -229.36m | 46.08m | 23.68k | -- | -- | -- | 0.0167 | -16.09 | -16.09 | 192.96 | -6.11 | 1.60 | -- | 7.73 | 116,316.30 | -12.69 | -3.45 | -19.55 | -4.73 | 15.15 | 18.36 | -7.93 | -2.50 | -- | 0.1004 | 1.07 | -- | 1.32 | 13.05 | 1.56 | -- | 20.54 | -- |
| Holder | Shares | % Held |
|---|---|---|
| Coliseum Capital Management LLCas of 31 Mar 2025 | 4.49m | 31.38% |
| Neuberger Berman Investment Advisers LLCas of 31 Mar 2025 | 2.02m | 14.12% |
| BlackRock Fund Advisorsas of 31 Mar 2025 | 733.56k | 5.13% |
| The Vanguard Group, Inc.as of 31 Mar 2025 | 596.60k | 4.17% |
| D. E. Shaw & Co. LPas of 31 Mar 2025 | 507.64k | 3.55% |
| Morgan Stanley & Co. LLCas of 31 Mar 2025 | 431.99k | 3.02% |
| SSgA Funds Management, Inc.as of 31 Mar 2025 | 422.91k | 2.96% |
| Two Sigma Advisers LPas of 31 Mar 2025 | 287.30k | 2.01% |
| UBS Securities LLCas of 31 Mar 2025 | 260.78k | 1.82% |
| Geode Capital Management LLCas of 31 Mar 2025 | 248.32k | 1.74% |
